Tonix Pharmaceuticals Holding Corp (TNXP) saw an uptrend of 8.13% in the recent trading with $16.9 being its most recent. The current price level -75.85% lower than the highest price of $69.97 marked by the stock while trading over the past 52-weeks, whereas it is 150.00% higher than the lowest price of $6.76 the company dropped to over past 52-weeks. The latest news story on TNXP appeared in (GlobeNewswire) under the title “Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026”.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 5 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
Tonix Pharmaceuticals Holding Corp Earnings – What Happened With TNXP
Coming around sales and income figures on TNXP Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Tonix Pharmaceuticals Holding Corp – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 12.79 million. TNXP does have institutional investors; and they hold 23.33% of the stock.
As on 2024-06-30, PRUDENTIAL FINANCIAL INC was the top most holder in Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) with an ownership of 97707.0 shares of the company or 0.0239 of the stake worth $68141.0. The filing also reveals ALYESKA INVESTMENT GROUP, L.P. as the second largest holder in the company with a control over 0.0153 of the outstanding shares. Its stake is worth $43588.0 for having 62500.0 shares in hand.
ACADIAN ASSET MANAGEMENT LLC also came holding a key position in the company during the recent quarter and it now holds 0.0141 of the outstanding shares. With this there are now 103.0 institutions which have possession in TNXP’s shares.
Key Metrics for TNXP
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Tonix Pharmaceuticals Holding Corp has a debt to equity ratio of 0.00.
